期刊文献+

EB病毒潜伏膜蛋白1羧基端活化区域2蛋白特异性结合短肽的筛选

Screening of EB virus latent membrane protein 1 C-terminal activating region 2 binding oligopeptides
原文传递
导出
摘要 目的 利用噬菌体12肽库筛选能与EB病毒潜伏膜蛋白1(LMPl)羧基端活化区域(CTAR)2蛋白特异性结合的短肽.方法 用纯化的CTAR2蛋白筛选噬菌体12肽库.通过夹心ELISA方法分析噬菌体克隆与CTAR2蛋白的亲和力.利用硝酸纤维膜斑点印迹法进行阳性克隆鉴定,并对阳性克隆进行测序及序列分析.结果 CTAR2蛋白对噬菌体12肽库进行3轮筛选,第3轮的产率是第1轮的143倍[(3.0×10^-6)/(2.1×10^-8)],噬菌体克隆得到较好的富集.ELISA方法提示筛选出来的噬菌体克隆能与CTAR2蛋白高效结合.硝酸纤维膜斑点印迹法证实阳性率达到100%.测序结果显示噬菌体上的短肽有共同序列:GLKHHSPGLLLY.结论 筛选出与CTAR2蛋白特异性结合的短肽序列GLKHHSPGLLLY,为研究LMP1致瘤机制和开发拮抗LMP1蛋白的小分子短肽类药物提供实验依据. Objective To screen the oligopeptide with specific affinity to C-terminal activating region 2 (CTAR2) of EB virus latent membrane protein 1 (LMP1) by using the Ph D-12 Phage Display Peptide Library kit.Methods Purified CTAR2 protein was used to screen oligopeptide from Ph D -12Phage Display Peptide Library.Affinity of phage clones to CTAR2 was identified by sandwich ELISA.Dot blot assay was applied for identifying positive clones.DNA sequencing and analysis for these positive clones were performed.Results Yield of oligopeptide screened by CTAR2 protein in Round Ⅲ was 143 times of Round I [ (3.0× 10^-6)/(2.1 × 10^-8) ],with satisfactory enrichment of phage clones.All the screened clones efficiently bound to CTAR2 as shown by sandwich ELISA,and the positive rate of binding was 100% as confirmed by Dot blot assay.A common sequence of the oligopeptide on phages (GLKHHSPGLLLY) was detected by DNA sequencing.Conclusion A oligopeptide sequence GLKHHSPGLLLY binding to CTAR2 of EBV LMP1 is screened,which provides a laboratory evidence for further research on the role of LMP1 in oncogenesis and for development of small molecule vaccines against LMP 1.
出处 《中华生物医学工程杂志》 CAS 2011年第5期429-433,共5页 Chinese Journal of Biomedical Engineering
基金 国家自然科学基金(39970292) 广东省自然科学基金(990183) 广州医学院基金项目(03-K-54)
关键词 EB病毒 潜伏膜蛋白1 C端活化区域2 噬菌体随机肽库 鼻咽癌 Epstein-barr virus Latent membrane protein 1 C-terminal activating region 2 Phage display peptide library Nasopharyngeal carcinoma
  • 相关文献

参考文献6

  • 1Izumi KM, Kaye KM, Kieff ED . Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primaru B-lymhocyte growth transformation. J Virol, 1994,68 : 4369-4376.
  • 2Vasef MA,Ferlito A,Weiss LM.Nasopharyngeal carcinoma,with emphasis on its relationshio to Epstein-Barr virus. Ann Otol Rhinol Laryngol,1997,106:348-356.
  • 3余琳,张雪雁,杨英.EB病毒LMP1 CTAR23蛋白特异性结合短肽的筛选[J].热带医学杂志,2010,10(4):406-409. 被引量:2
  • 4Kμlwichit W,Edwards RH,Davenport EM,et al.Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymohoma in transgenic mice.Proc Natl Acad Sci USA,1998,95:11963-11968.
  • 5Nakamura H,Ishii C,Suehiro M,et al.The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.Virus Res,2008,131:170-179.
  • 6Funke SA,Willbold D.Mirror image phage display-a method to generate D-peptide ligands for use in diagnostic or therapeutical applications.Mol Biosyst,2009,5:783-786.

二级参考文献9

  • 1Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphotytes transforms established rodent cells [J]. Cell, 1985,43(3 Pt2) :831-840.
  • 2Coffin WF 3rd, Erickson KD, Hoedt-Miller M,et al. The cytoplasmic amino-teminus of the latent membrane protein-1 of epstein-barr virus : relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain [ J ]. Oneogene, 2001,20 (38) : 5313 - 5330.
  • 3Gires O, Kohlhuber F, Kilger E, et al. Latent membrane protein 1 of epstein-barr virus interacts with JAK3 and activeates STAT proteins [J]. EMBO J, 1999, 18 ( 11 ) : 3064- 3073.
  • 4Ikeda O, Sekine Y, Mizushima A, et al. BS69 negatively regulates the canonical NF-kappaB activation induced by Epstein-Barr virus-derived LMP1 [J ].FEBS Lett, 2009,583 (10) :1567-1574.
  • 5Faumont N, Le Clorennec C, Teira P, et al. Regulation of DNA polymerase beta by the LMP1 oncoprotein of EBV through the nuclear factor-kappaB pathway [J]. Cancer Res, 2009,69(12) :5177-5185.
  • 6Demetriades C, Mosialos G.The LMP1 promoter can be transactivated direetly byNF-kappaB [ J ]. J Virol, 2009,83 (10) : 5269-5277.
  • 7Wu C, Lo SL, Boulaire J, et al. A peptide-based carrier for intracellular delivery of proteins into malignant glial ceils in Vitro [ J ]. J Control Release, 2008,130 (2) : 140-145.
  • 8Chen B, Jin H, Wu K.Potential role of vascular targeted therapy to combat against tumor[J]. Expert Opin Drug Deliv, 2009,6(7) :719-726.
  • 9McCregor DP.Discovering and improving novel peptide therapeutics [ J ]. Curr Opin Pharmacol, 2008,8 (5) : 616-619.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部